Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC Transplantation in Infants with Biliary Atresia
NCT06564740Recruiting
- Sponsor
- Esenyurt Necmi Kadıoğlu State Hospital
- Start
- Jun 2024
- Primary completion
- May 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of human umbilical cord mesenchymal stem cells in biliary atresia (2 arms), sponsored by Esenyurt Necmi Kadıoğlu State Hospital. Primary endpoint: Adverse events at 2 years. Started Jun 2024; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
biliary atresia
Beyond the preview
Go deeper on NCT06564740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06564740.